Search Results

You are looking at 251 - 260 of 1,450 items for :

  • "characteristics" x
  • Refine by Access: All x
Clear All
Full access

Johannes Uhlig, Michael Cecchini, Amar Sheth, Stacey Stein, Jill Lacy, and Hyun S. Kim

KRAS wild-type). Table 1. Patient and Tumor Characteristics According to Microsatellite Status Table 2. Patient and Tumor Characteristics According to KRAS Status CRC Mutation Status: Impact on OS and Interaction With Tumor Location For survival

Full access

Daniel E. Lage, Areej El-Jawahri, Charn-Xin Fuh, Richard A. Newcomb, Vicki A. Jackson, David P. Ryan, Joseph A. Greer, Jennifer S. Temel, and Ryan D. Nipp

characteristics of patients with and without ADL impairment. We then sought to assess the relationship between patients’ functional impairment at the time of hospital admission, their symptom burden, and their subsequent clinical outcomes, including LoS, rates of

Full access

Ryan D. Nipp, Brandon Temel, Charn-Xin Fuh, Paul Kay, Sophia Landay, Daniel Lage, Esteban Franco-Garcia, Erin Scott, Erin Stevens, Terrence O’Malley, Supriya Mohile, William Dale, Lara Traeger, Ardeshir Z. Hashmi, Vicki Jackson, Joseph A. Greer, Areej El-Jawahri, and Jennifer S. Temel

. Study Measures Sociodemographic and Clinical Characteristics Participants completed baseline study measures before randomization, and were asked to self-report their sex, race, relationship status, employment status, education level, annual income, and

Full access

Michael Xiang, A. Dimitrios Colevas, F. Christopher Holsinger, Quynh-Thu X. Le, and Beth M. Beadle

of death to SEER site recode field. Acute toxicities were analyzed within 3 months of the end of RT, as previously described. 13 Statistical Analysis Baseline characteristics were compared using the chi-square or Wilcoxon rank sum test. Multivariable

Full access

Emily van Seventer, J. Peter Marquardt, Amelie S. Troschel, Till D. Best, Nora Horick, Chinenye Azoba, Richard Newcomb, Eric J. Roeland, Michael Rosenthal, Christopher P. Bridge, Joseph A. Greer, Areej El-Jawahri, Jennifer Temel, Florian J. Fintelmann, and Ryan D. Nipp

explore relationships between participant characteristics and muscle, we used multivariable linear regression, including patient age, sex, race, marital status, education level, insurance type, CCI score, time since cancer diagnosis, cancer type, BMI, and

Full access

Zi-Xian Wang, Hao-Xiang Wu, Ming-Ming He, Ying-Nan Wang, Hui-Yan Luo, Pei-Rong Ding, Dan Xie, Gong Chen, Yu-Hong Li, Feng Wang, and Rui-Hua Xu

clinical outcomes of left- and right-sided CRC tumors. 2 – 7 These differing characteristics are associated with differential prognosis, and patients with right-sided CRC are reported to have a worse prognosis. 8 , 9 A recent meta-analysis including 14

Full access

Michael G. Milligan, Angel M. Cronin, Yolonda Colson, Kenneth Kehl, Debra N. Yeboa, Deborah Schrag, and Aileen B. Chen

characteristics of patients included in our sample, grouped by receipt of brain imaging. Categorical variables were reported as counts and percentages, and groups were compared using chi-square tests for significance. Continuous variables were reported as medians

Full access

Claudia S.E.W. Schuurhuizen, Annemarie M.J. Braamse, Aartjan T.F. Beekman, Pim Cuijpers, Mecheline H.M. van der Linden, Adriaan W. Hoogendoorn, Hans Berkhof, Dirkje W. Sommeijer, Vera Lustig, Suzan Vrijaldenhoven, Haiko J. Bloemendal, Cees J. van Groeningen, Annette A. van Zweeden, Maurice J.D.L. van der Vorst, Ron Rietbroek, Cathrien S. Tromp-van Driel, Machteld N.W. Wymenga, Peter W. van der Linden, Aart Beeker, Marco B. Polee, Erdogan Batman, Maartje Los, Aart van Bochove, Jan A.C. Brakenhoff, Inge R.H.M. Konings, Henk M.W. Verheul, and Joost Dekker

-described effective interventions using a stepped care–oriented approach (S). At baseline, the TES and CAU groups were comparable regarding sociodemographic and most clinical characteristics ( Table 1 and supplemental eTable 3 ). Patients in the TES arm received

Full access

William R. Kennedy, Christopher Tricarico, Prashant Gabani, Ashley A. Weiner, Michael B. Altman, Laura L. Ochoa, Maria A. Thomas, Julie A. Margenthaler, Souzan Sanati, Lindsay L. Peterson, Cynthia X. Ma, Foluso O. Ademuyiwa, and Imran Zoberi

for all statistical analyses. Results Patients and Treatment Characteristics A total of 153 patients with a median follow-up of 4.04 years (range, 0.51–13.97 years) were included in the study cohort. Patient characteristics and treatment strategies are

Full access

Davide Mauri, Antonis Valachis, Nikolaos P. Polyzos, Lamprini Tsali, Dimitris Mavroudis, Vassilis Georgoulias, and Giovanni Casazza

analyses could be retrieved from only 13 studies. 10 – 12 , 21 – 30 A flow chart indicating the identification of randomized controlled trials for inclusion in the meta-analysis is reported in Figure 1 . Characteristics of Trials Table 1